What is the main business of Inpharm Support?

The main business activity of Inpharm Support focuses on renting and operating of own or leased real estate.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 23, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Chełmżyńska 249, 04-458 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $2,326 in 2024, which is an increase of 33.7% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $1,609, meaning the company increased its profit by 53.5%.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $718 in 2024, representing 100% of all operating expenses.

Inpharm Supportsp. z o.o.

Renting and operating of own or leased real estate

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-11-23

Share capital

5,000.00 PLN

Activity description

Inpharm Support has supplied original medicines through parallel imports since 2006, and manufactures and distributes them to pharmacies in Poland. Under the Nexon Pharma brand, the company also manufactures and distributes dietary supplements, medical devices and cosmetics.

Registered address

ul. Chełmżyńska 249, 04-458 Warszawa, Poland

Website

inpharm.pl

Phone

Social media

Electronic delivery address

AE:PL-54858-55988-BBGFH-08

Financials

Revenue history

Filing timeliness

1 of 5 financial statements was filed late (for 2021, 56 days late).

202523/06/2026
202427/06/2025
202321/06/2024
202228/06/2023
202109/09/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 78.76MedianUSD 193.80kAverageUSD 1.37m

Net profit

This companyUSD -1.14kMedianUSD 7.25kAverageUSD 125.83k

Operating costs

This companyUSD 1.22kMedianUSD 132.33kAverageUSD 940.78k

Assets

This companyUSD 2.82kMedianUSD 765.00kAverageUSD 6.95m

Industry

Authorized Representatives

Agata Zalega Bernaciak – Management Board Member

Sławomir Radosław Bernaciak – President of the Management Board

Marzena Teresa Idzikowska – Management Board Member

Manner of representation

Each member of the management board is entitled to make declarations of will and sign on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Mkv Invest Fundacja Rodzinna w Organizacji	40	$540.25	40%
Samm Fundacja Rodzinna w Organizacji	60	$810.37	60%

Beneficial owners

Person	Rights

Subsidiaries

	Name	Stake
	Nexon Pharmasp. z o.o. + limited partnership	–

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
MLP Spv IIsp. z o.o.	$689.11	mlpgroup.com
Swisslaser Investsp. z o.o.	$603.36	swisslaser.pl
Accolade Pl 46sp. z o.o.	$501.18	accolade.eu
Accolade Pl Xxxiiisp. z o.o.	$277.00	accolade.eu
Accolade Pl 47sp. z o.o.	$230.92	accolade.eu
R4R Spv 10sp. z o.o.	$214.01	r4r.pl
CTP Property Nu Polandsp. z o.o.	$93.64	ctp.eu
CTP Property Lambda Polandsp. z o.o.	$61.42	ctp.eu
Karuzela Mysłowicesp. z o.o.	$35.03	karuzelamyslowice.pl
Stokado Buarsp. z o.o.	$16.07	stokado.pl

Change history

Date	Event
2021-03-26	Address change (Ul. Towarowa 28, 00-839, Warszawa → Ul. Chełmżyńska 249, 04-458, Warszawa)
2021-03-26	Name change (Cl129 → Inpharm Support)
2020-11-23	Entered in the register

FAQ

Last updated: 2026-06-23